You may also like
Effect of Erythropoietin in Patients with Acute Myocardial Infarction: Five-Year Results of the REVIVAL-3 Trial
Erythropoietin (EPO) has been suggested to promote cardiac repair after MI. However, the randomized, double-blind, placebo controlled REVIVAL-3 trial showed that short term high dose EPO in timely reperfused myocardium does not improve left ventricular ejection fraction after 6 months.
1 min read
Quality Control Procedures in Autotransfusion (EP Video)
John Riveria discusses often misunderstood quality control procedures in autotransfusion cases (49 minutes).
1 min read
Platelet Gel Service Support Pack Released
PPAI Medical Inc. has recenetly released a PRP Support Pack for anyone interested in providing PRP services. This support pack is in […]
1 min read